FM
HALO icon

Foster & Motley’s Halozyme HALO Stock Holding History

Foster & Motley’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.55M Buy
24,050
+1,218
+5% +$85.9K 0.08% 192
2025
Q4 		$1.54M Sell
22,832
-377
-2% -$25.4K 0.08% 187
2025
Q3 		$1.7M Sell
23,209
-320
-1% -$21.3K 0.09% 186
2025
Q2 		$1.22M Sell
23,529
-377
-2% -$21.5K 0.07% 212
2025
Q1 		$1.52M Buy
23,906
+626
+3% +$36.4K 0.1% 183
2024
Q4 		$1.11M Buy
23,280
+12,630
+119% +$648K 0.07% 207
2024
Q3 		$609K Buy
+10,650
New +$611K 0.04% 255

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Foster & Motley's HALO Position: Q1 2026 in Review

Foster & Motley increased its Halozyme (HALO) stake by 5.3% in Q1 2026, buying an estimated $85.9K and bringing the position to 24,050 shares worth $1.55M. The position accounts for 0.08% of the portfolio, ranked #192.

Foster & Motley first reported a position in HALO in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.7M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Foster & Motley held 24,050 shares of Halozyme worth $1.55M as of Q1 2026.
  • Foster & Motley bought 1,218 Halozyme shares in Q1 2026, an estimated $85.9K.
  • Halozyme made up 0.08% of Foster & Motley's portfolio in Q1 2026, its #192 holding.
  • Foster & Motley first reported a position in Halozyme in Q3 2024 and has held it in 7 quarters since.
  • Foster & Motley's Halozyme position peaked at $1.7M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Foster & Motley's 13F filing for Q1 2026, filed 21 Apr 2026.